Publications

  • Sindhu Koushik, Nivedita Joshi, Shruthi Nagaraju, Sameer Mahmood, Krishna Mudeenahally, Ramya Padmavathy, Sooriya Kumar Jegatheesan, Ramesh Mullangi and Sriram Rajagopal

    PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis

    EXPERT OPINION ON THERAPEUTIC TARGETS, 2017

    http://dx.doi.org/10.1080/14728222.2017.1294160

  • Manish Kumar Thakur, Swarnakumari Bridukota, Srinivasan Swaminathan, Sivarama Krishna Battula, Sarvanan Vadivelu, Rajiv Tyagi and Ramchandraiah Gosu

    Biochemical and Biophysical Research Communications 482(4):1289-95(2017)

    Co-crystal structures of PTK6:  with dasatinib at 2.24Å, with novel imidazo [1,2-a] pyrazin-8-amine derivative inhibitor at 1.70Å resolution

    http://dx.doi.org/10.1016/j.bbrc.2016.12.030

  • Archana Venkataramana Karanth, Radhika Radha Maniswami, Seema Prashanth, Hemalatha Govindaraj, Ramya Padmavathy, Sooriya Kumar Jegatheesan, Ramesh Mullangi and Sriram Rajagopal

    Emerging role of SETDB1 as a therapeutic target

    EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, VOL. 21, NO. 3, 319–331

    http://dx.doi.org/10.1080/14728222.2017.1279604